Dopamine Plasma Membrane Transport Proteins
"Dopamine Plasma Membrane Transport Proteins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Sodium chloride-dependent neurotransmitter symporters located primarily on the PLASMA MEMBRANE of dopaminergic neurons. They remove DOPAMINE from the EXTRACELLULAR SPACE by high affinity reuptake into PRESYNAPTIC TERMINALS and are the target of DOPAMINE UPTAKE INHIBITORS.
Descriptor ID |
D050483
|
MeSH Number(s) |
D12.776.157.530.450.625.124 D12.776.157.530.562.374.500.500 D12.776.157.530.937.500 D12.776.543.585.450.625.124 D12.776.543.585.562.374.500.500 D12.776.543.585.937.500
|
Concept/Terms |
Dopamine Plasma Membrane Transport Proteins- Dopamine Plasma Membrane Transport Proteins
- Dopamine Transporter
- Transporter, Dopamine
- SLC6A3 Protein
- Protein, SLC6A3
- Solute Carrier Family 6 (Neurotransmitter Transporter), Member 3 Protein
- Dopamine Transporter Proteins
- Transporter Proteins, Dopamine
- Dopamine Carriers
- Carriers, Dopamine
- DAT Dopamine Transporter Proteins
- Neurotransmitter Transport Proteins, Dopamine-Specific
- Neurotransmitter Transport Proteins, Dopamine Specific
- Neurotransmitter Transporters, Dopamine-Specific
- Dopamine-Specific Neurotransmitter Transporters
- Neurotransmitter Transporters, Dopamine Specific
- Transporters, Dopamine-Specific Neurotransmitter
- DAT Dopamine Transporter
- Dopamine Transporter, DAT
- Transporter, DAT Dopamine
- Dopamine Plasma Membrane Transporter Proteins
|
Below are MeSH descriptors whose meaning is more general than "Dopamine Plasma Membrane Transport Proteins".
Below are MeSH descriptors whose meaning is more specific than "Dopamine Plasma Membrane Transport Proteins".
This graph shows the total number of publications written about "Dopamine Plasma Membrane Transport Proteins" by people in this website by year, and whether "Dopamine Plasma Membrane Transport Proteins" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 0 | 1 | 1 |
2000 | 0 | 1 | 1 |
2001 | 0 | 1 | 1 |
2002 | 0 | 1 | 1 |
2004 | 0 | 1 | 1 |
2005 | 1 | 1 | 2 |
2006 | 0 | 1 | 1 |
2007 | 2 | 1 | 3 |
2008 | 1 | 1 | 2 |
2009 | 1 | 1 | 2 |
2010 | 1 | 0 | 1 |
2011 | 1 | 1 | 2 |
2012 | 0 | 1 | 1 |
2013 | 0 | 1 | 1 |
2016 | 2 | 0 | 2 |
2018 | 1 | 0 | 1 |
2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Dopamine Plasma Membrane Transport Proteins" by people in Profiles.
-
Novel Benzofuran Derivatives Induce Monoamine Release and Substitute for the Discriminative Stimulus Effects of 3,4-Methylenedioxymethamphetamine. J Pharmacol Exp Ther. 2024 Sep 18; 391(1):22-29.
-
The dopamine transporter VNTR polymorphism moderates the relationship between acute response to alcohol and future alcohol use disorder symptoms. Addict Biol. 2019 09; 24(5):1109-1118.
-
Evaluation of parkinsonism and striatal dopamine transporter loss in patients with spinocerebellar ataxia type 6. J Neurol. 2016 Nov; 263(11):2302-2307.
-
PKC phosphorylates residues in the N-terminal of the DA transporter to regulate amphetamine-induced DA efflux. Neurosci Lett. 2016 05 27; 622:78-82.
-
Dopamine dynamics and cocaine sensitivity differ between striosome and matrix compartments of the striatum. Neuropharmacology. 2016 09; 108:275-83.
-
Do dopamine gene variants and prenatal smoking interactively predict youth externalizing behavior? Neurotoxicol Teratol. 2013 Nov-Dec; 40:67-73.
-
Influence of a dopamine pathway additive genetic efficacy score on smoking cessation: results from two randomized clinical trials of bupropion. Addiction. 2013 Dec; 108(12):2202-11.
-
The evaluation of AZ66, an optimized sigma receptor antagonist, against methamphetamine-induced dopaminergic neurotoxicity and memory impairment in mice. Int J Neuropsychopharmacol. 2013 Jun; 16(5):1033-44.
-
Pharmacological evaluation of SN79, a sigma (s) receptor ligand, against methamphetamine-induced neurotoxicity in vivo. Eur Neuropsychopharmacol. 2013 Aug; 23(8):960-71.
-
Dysregulation of D2-mediated dopamine transmission in monkeys after chronic escalating methamphetamine exposure. J Neurosci. 2012 Apr 25; 32(17):5843-52.